Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8292642 | Biochemical and Biophysical Research Communications | 2018 | 9 Pages |
Abstract
Overexpression of miR-196b suppresses SOCS2 in human LSCC resulting in tumor progression and poor prognosis. miR-196b is a potential marker for prognosis assessment and targeting miR-196b may be a novel valuable strategy for the treatment of LSCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Xudong Zhao, Wei Zhang, Wenyue Ji,